Cleared Traditional

K120169 - INTERLAB IFE TEST USING G 26 VER. 2.0 INSTRUMENT

K120169 is an FDA 510(k) clearance for INTERLAB IFE TEST USING G 26 VER. 2.0 I..., manufactured by Grifols USA, LLC. The device is a Class 2 Immunology device with product code CFF cleared through the Traditional 510(k) pathway after a 218-day FDA review.

K120169 · Grifols USA, LLC · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2012
Decision
218d
Days
Class 2
Risk

K120169 is an FDA 510(k) clearance for the INTERLAB IFE TEST USING G 26 VER. 2.0 INSTRUMENT. Classified as Immunoelectrophoretic, Immunoglobulins, (g, A, M) (product code CFF), Class II - Special Controls.

Submitted by Grifols USA, LLC (East Stroudsburg, US). The FDA issued a Cleared decision on August 24, 2012 after a review of 218 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Grifols USA, LLC devices

FDA 510(k) Submission Details - K120169

510(k) Number K120169 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 19, 2012
Decision Date August 24, 2012
Days to Decision 218 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
114d slower than avg
Panel avg: 104d · This submission: 218d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CFF Device Classification - Class 2, Special Controls

Product Code CFF Immunoelectrophoretic, Immunoglobulins, (g, A, M)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CFF Immunoelectrophoretic, Immunoglobulins, (g, A, M)

All 22
Devices cleared under the same product code (CFF) and FDA review panel - the closest regulatory comparables to K120169.
HYDRASHIFT 2/4 daratumumab, daratumumab Control
K172195 · Sebia · Jan 2018
CAPI 3 IMMUNOTYPING, CAPILLARYS 3 TERA, IT/IF CONTROL
K161928 · Sebia · Dec 2016
MINICAP Immunotyping using the MINICAP and the MINICAP FLEX-PIERCING
K143483 · Sebia · Jan 2015
CAPILLARYS IMMUNOTYPING, MODEL 2100
K082085 · Sebia · Apr 2009
MINICAP IMMUNOTYPING, MODEL: 2300
K082388 · Sebia · Apr 2009
SPIFE IFE-15 PENTAVALENT, MODEL 3456, SPIFE IFE-9 PENTAVALENT KIT, MODEL 3457, SPIFT IFE-6 PENTAVALENT KIT, MODEL 3458
K061069 · Helena Laboratories · Jul 2006